Palvella Therapeutics (PVLA) Institutional Ownership $113.99 0.00 (0.00%) Closing price 05/22/2026 04:00 PM EasternExtended Trading$113.90 -0.09 (-0.08%) As of 05/22/2026 04:10 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock Institutional Ownership Changes (13F Filings) for Palvella Therapeutics (NASDAQ:PVLA)CurrentInstitutional OwnershipPercentage40.11%Number ofInstitutional Buyers(last 12 months)85TotalInstitutional Inflows(last 12 months)$508.54MNumber ofInstitutional Sellers(last 12 months)29TotalInstitutional Outflows(last 12 months)$120.71M Get PVLA Insider Trade Alerts Want to know when executives and insiders are buying or selling Palvella Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Subscribe Now View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Skip Chart & View Institutional Buying and Selling Data PVLA Institutional Buying and Selling by Quarter Palvella Therapeutics Major Shareholders & Ownership History ExportReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails5/20/2026 Arete Wealth Advisors LLC17,470$2.18M0.1%N/A0.122% 5/19/2026 Bank of America Corp DE37,972$4.73M0.0%+25.4%0.265% 5/19/2026 Arete Wealth Advisors LLC17,470$2.18M0.2%N/A0.122% 5/16/2026 The Manufacturers Life Insurance Company 17,907$2.23M0.0%+688.9%0.125% 5/16/2026 First Light Asset Management LLC980,758$122.25M11.0%+38.3%6.838% 5/14/2026 Renaissance Technologies LLC17,970$2.24M0.0%-20.2%0.125% 5/14/2026 Siren L.L.C.257,485$32.10M0.9%+243.3%1.796% 5/14/2026 Sei Investments Co.16,663$2.08M0.0%+42.2%0.116% 5/7/2026 WCM Investment Management LLC39,964$4.98M0.0%N/A0.279% 5/7/2026 KBC Group NV224$28K0.0%N/A0.002% Get the Latest News and Ratings for PVLA and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Palvella Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 5/7/2026 Swiss National Bank19,400$2.42M0.0%+36.6%0.135% 5/6/2026 Jennison Associates LLC640,611$79.85M0.1%+65.3%4.474% 5/5/2026 Bank of New York Mellon Corp18,041$2.25M0.0%+10.9%0.126% 5/4/2026 Calamos Advisors LLC9,804$1.22M0.0%N/A0.069% 5/4/2026 Emerald Mutual Fund Advisers Trust105,820$13.19M0.6%N/A0.739% 5/4/2026 Emerald Advisers LLC161,500$20.13M0.6%N/A1.129% 5/1/2026 Fifth Third Bancorp19,947$2.49M0.0%N/A0.139% 4/25/2026 Keybank National Association OH1,827$228K0.0%N/A0.013% 4/21/2026 Clio Asset Management LLC90,757$11.31M9.5%-1.0%0.634% 4/16/2026 SG Americas Securities LLC2,472$308K0.0%-8.1%0.017% 2/19/2026 Invesco Ltd.54,273$5.68M0.0%+11.6%0.458% 2/18/2026 XTX Topco Ltd4,103$429K0.0%N/A0.035% 2/18/2026 Virtus Investment Advisers LLC2,698$282K0.1%N/A0.023% 2/18/2026 Wellington Management Group LLP22,403$2.35M0.0%-5.5%0.189% 2/18/2026 Superstring Capital Management LP25,469$2.67M1.4%N/A0.215% 2/18/2026 Suvretta Capital Management LLC892,400$93.41M1.9%+8.5%7.537% 2/18/2026 Perceptive Advisors LLC266,287$27.87M0.5%-32.6%2.249% 2/18/2026 Millennium Management LLC3,480$364K0.0%-87.1%0.029% 2/18/2026 Janus Henderson Group PLC3,600$376K0.0%N/A0.030% 2/18/2026 Catalio Capital Management LP10,452$1.09M0.2%-13.0%0.088% 2/18/2026 Cinctive Capital Management LP8,707$911K0.0%N/A0.074% 2/18/2026 Artia Global Partners LP59,200$6.20M0.9%N/A0.500% 2/18/2026 Balyasny Asset Management L.P.108,880$11.40M0.0%-34.6%0.920% 2/18/2026 BVF Inc. IL879,009$92.01M3.1%-24.3%7.424% 2/17/2026 MPM Bioimpact LLC205,745$21.54M2.5%+205.2%1.738% 2/17/2026 First Light Asset Management LLC709,141$74.23M5.7%+30.9%5.989% 2/17/2026 Price T Rowe Associates Inc. MD4,090$429K0.0%+11.8%0.035% 2/17/2026 California State Teachers Retirement System6,919$724K0.0%+1,512.8%0.058% 2/17/2026 Russell Investments Group Ltd.1,229$129K0.0%+116.4%0.010% 2/17/2026 State of Wisconsin Investment Board4,513$472K0.0%N/A0.038% SpaceX eyes a 1.75 trillion valuation - here's what to know (Ad)Elon Musk's team has quietly filed confidential paperwork with the SEC for what Bloomberg estimates could be a $1.75 trillion IPO - larger than Saudi Aramco and any tech offering in history. CNBC calls it 'the big market event of 2026.' According to former tech executive and angel investor Jeff Brown, there's a way to claim a stake before the public filing drops, starting with as little as $500.See how to get positioned in SpaceX before the announcement goes public2/17/2026 Summit Partners Public Asset Management LLC389,420$40.76M0.8%+1,016.0%3.289% 2/17/2026 Artisan Partners Limited Partnership211,553$22.14M0.0%N/A1.787% 2/17/2026 Fred Alger Management LLC150,026$15.70M0.1%-19.7%1.267% 2/17/2026 Royal Bank of Canada2,297$240K0.0%-17.4%0.019% 2/16/2026 Verition Fund Management LLC11,932$1.25M0.0%N/A0.101% 2/16/2026 Mariner LLC11,615$1.22M0.0%-43.9%0.098% 2/16/2026 NEXTBio Capital Management LP82,686$8.66M5.1%N/A0.698% 2/16/2026 Eventide Asset Management LLC101,748$10.65M0.2%N/A0.859% 2/16/2026 Avidity Partners Management LP19,300$2.02M0.6%N/A0.163% 2/16/2026 Barclays PLC25,136$2.63M0.0%+157.1%0.212% 2/13/2026 Marshall Wace LLP9,484$993K0.0%N/A0.080% 2/13/2026 The Manufacturers Life Insurance Company 2,270$238K0.0%N/A0.019% 2/13/2026 Rafferty Asset Management LLC15,734$1.65M0.0%N/A0.133% 2/13/2026 Siren L.L.C.75,000$7.85M0.2%N/A0.633% 2/13/2026 Charles Schwab Investment Management Inc.21,633$2.26M0.0%+3.0%0.183% 2/13/2026 State Street Corp420,462$44.01M0.0%+206.3%3.551% 2/13/2026 UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC47,681$4.99M0.0%N/A0.403% 2/13/2026 Wells Fargo & Company MN10,928$1.14M0.0%+48.8%0.092% 2/12/2026 Renaissance Technologies LLC22,530$2.36M0.0%-74.9%0.190% 2/12/2026 Federated Hermes Inc.368,038$38.52M0.1%+8.6%3.108% 2/12/2026 New York State Common Retirement Fund17,315$1.81M0.0%+518.4%0.146% 2/12/2026 Alps Advisors Inc.9,716$1.02M0.0%+77.1%0.082% 2/12/2026 Swiss National Bank14,200$1.49M0.0%N/A0.120% 2/12/2026 Nuveen LLC19,576$2.05M0.0%+54.1%0.165% 2/12/2026 Group One Trading LLC332$35K0.0%+151.5%0.003% 2/11/2026 Deutsche Bank AG6,594$690K0.0%+8.7%0.056% 2/11/2026 Letko Brosseau & Associates Inc.3,500$366K0.0%-32.7%0.030% 2/11/2026 LPL Financial LLC3,448$361K0.0%N/A0.029% 2/11/2026 Clearbridge Investments LLC60,628$6.35M0.0%N/A0.512% 2/10/2026 Goldman Sachs Group Inc.98,935$10.36M0.0%-58.2%0.836% 2/10/2026 Peapack Gladstone Financial Corp3,000$314K0.0%N/A0.025% 2/10/2026 Intech Investment Management LLC3,469$363K0.0%-16.0%0.029% 2/9/2026 Geode Capital Management LLC178,992$18.74M0.0%+6.5%1.512% 2/9/2026 Royce & Associates LP30,010$3.14M0.0%-39.4%0.253% 2/9/2026 Blue Owl Capital Holdings LP40,259$4.21M0.3%-57.7%0.340% 2/9/2026 Lisanti Capital Growth LLC41,470$4.34M1.0%N/A0.350% 2/6/2026 Legato Capital Management LLC11,385$1.19M0.1%N/A0.096% 2/6/2026 PSP Research LLC5,084$532K0.5%N/A0.043% 2/6/2026 Profund Advisors LLC5,813$608K0.0%N/A0.049% 2/5/2026 Baader Bank Aktiengesellschaft3,131$326K0.0%N/A0.026% 2/2/2026 Chung Wu Investment Group LLC2,600$272K0.2%+1,200.0%0.022% 1/30/2026 Sigma Planning Corp6,500$680K0.0%N/A0.055% 1/30/2026 Jennison Associates LLC387,483$40.56M0.0%+262.4%3.273% 1/30/2026 Certuity LLC3,000$314K0.0%N/A0.025% 1/29/2026 Deltec Asset Management LLC2,400$251K0.0%-80.8%0.020% 1/29/2026 UBS Group AG36,505$3.82M0.0%+78.6%0.308% 1/29/2026Vanguard Group Inc.560,616$58.68M0.0%+13.3%4.735% 1/29/2026 China Universal Asset Management Co. Ltd.1,600$167K0.0%N/A0.014% 1/9/2026 SG Americas Securities LLC2,689$281K0.0%N/A0.023% 1/1/2026 JPMorgan Chase & Co.4,338$272K0.0%+33.7%0.037% Before you buy SpaceX shares, consider this alternative approach (Ad)SpaceX has confidentially filed for an IPO with the SEC, targeting a June 2026 listing at a valuation exceeding $1.75 trillion - potentially the largest IPO in history. But one expert says buying shares directly may not be the smartest move. There is a lesser-known way to tap into this windfall that most investors haven't considered.Discover the overlooked SpaceX IPO strategy before the June listing11/17/2025 Woodline Partners LP345,749$21.68M0.1%-22.4%2.921% 11/17/2025 Summit Partners Public Asset Management LLC34,895$2.19M0.0%N/A0.295% 11/17/2025 Mariner LLC20,722$1.30M0.0%N/A0.175% 11/17/2025 Millennium Management LLC26,874$1.69M0.0%-91.5%0.227% 11/17/2025 MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.3,174$199K0.0%-15.4%0.027% 11/17/2025 Fred Alger Management LLC186,751$11.71M0.0%+1,279.1%1.578% 11/17/2025 First Light Asset Management LLC541,544$33.95M3.2%N/A4.575% 11/17/2025 Bank of America Corp DE4,689$294K0.0%+12.3%0.040% 11/17/2025 Boothbay Fund Management LLC25,532$1.60M0.0%N/A0.216% 11/17/2025 Apis Capital Advisors LLC10,000$627K0.1%N/A0.084% PVLA Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of PVLA shares? During the previous two years, 110 institutional investors and hedge funds held shares of Palvella Therapeutics. The most heavily invested institutionals were First Light Asset Management LLC ($122.25M), Suvretta Capital Management LLC ($93.41M), BVF Inc. IL ($92.01M), Jennison Associates LLC ($79.85M), Vanguard Group Inc. ($58.68M), State Street Corp ($44.01M), and Summit Partners Public Asset Management LLC ($40.76M).Learn more on Palvella Therapeutics' institutional investors. What percentage of Palvella Therapeutics' stock is owned by institutional investors? 40.11% of Palvella Therapeutics' stock is owned by institutional investors. Learn more on PVLA's institutional investor holdings. Which institutional investors have been buying Palvella Therapeutics' stock? Of the 103 institutional investors that purchased Palvella Therapeutics' stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: First Light Asset Management LLC ($980.76K), Suvretta Capital Management LLC ($892.40K), Frazier Life Sciences Management L.P. ($722.40K), BVF Inc. IL ($696.56K), Samsara BioCapital LLC ($679.49K), Jennison Associates LLC ($533.70K), and Adams Street Partners LLC ($409.67K). How much institutional buying is happening at Palvella Therapeutics? Institutional investors have bought a total of 5,633,601 shares in the last 24 months. This purchase volume represents approximately $508.54M in transactions. Which of Palvella Therapeutics' major shareholders have been selling company stock? Of the 29 institutional investors that sold Palvella Therapeutics' stock in the last 24 months, the following investors and hedge funds have sold the highest volume of shares: Millennium Management LLC ($311.51K), BVF Inc. IL ($282.24K), Goldman Sachs Group Inc. ($137.70K), Perceptive Advisors LLC ($128.81K), Adams Street Partners LLC ($110.68K), Woodline Partners LP ($99.87K), and Blue Owl Capital Holdings LP ($85K). How much institutional selling is happening at Palvella Therapeutics? Institutional investors have sold a total of 1,445,174 shares in the last 24 months. This volume of shares sold represents approximately $120.71M in transactions. Related Companies KYMR Institutional Ownership PTGX Institutional Ownership SYRE Institutional Ownership RYTM Institutional Ownership MIRM Institutional Ownership LNTH Institutional Ownership TGTX Institutional Ownership CNTA Institutional Ownership PTCT Institutional Ownership SRRK Institutional Ownership This page (NASDAQ:PVLA) was last updated on 5/25/2026 by MarketBeat.com Staff. From Our PartnersSpaceX eyes a 1.75 trillion valuation - here's what to knowElon Musk's team has quietly filed confidential paperwork with the SEC for what Bloomberg estimates could be a...Brownstone Research | Sponsored$30 stock to buy before Starlink goes public (WATCH NOW!)In the next 3 minutes… James Altucher – legendary investor and venture capitalist… And someone who’s kno...Paradigm Press | SponsoredYour book attachedBill Poulos is giving away his 'Safe Trade Options Formula' book for free - but only for a limited time throug...Profits Run | SponsoredMy feud with Zohran MamdaniEmmy-winning analyst releases his next big story Whitney Tilson shocked the nation on 60 Minutes when he ac...Stansberry Research | SponsoredSpaceX IPO hides a much bigger storyThe SpaceX IPO could be the biggest in history at $1.75 trillion - but the real story isn't the IPO itself. ...Weiss Ratings | SponsoredSpaceX will mint billionaires. You won't be one of them.By the time a company goes public, 95% of profits have already been made. Insiders bought SpaceX at $20 billio...Behind the Markets | SponsoredSatellite Images Spot Potential $10 Trillion Discovery'Dark Energy': Elon Musk's Next Potential $10 Trillion Move A highly secure site in West Texas now houses a...Altimetry | SponsoredHey, it's Jon Najarian. The SpaceX IPO is right around the corner. But I discovered Elon may have something BIGGER planned. Check this out before June 9th...After being invited to the SpaceX launch headquarters in Cape Canaveral from one of Elon's top lobbyists… Hall...Banyan Hill Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Palvella Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Palvella Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
